Advances in pulmonary delivery of nanoparticles

52Citations
Citations of this article
101Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Nanotechnology has potential in the development of novel and effective delivery of drugs within lungs. Different strategies have been utilized for pulmonary delivery of drugs, including the use of lipid-based delivery systems (liposomes, ISCOMs, SLNs), use of polymeric matrix (PLGA, poly caprolactone, cynoacrylates, gelatin), development of polysaccharide particulates (chitosan, alginates, Carbopol, etc.), biocompatible metallic inorganic particles (iron, gold, zinc), etc. This paper reviews various nanopaticulate approaches in the form of lipids, polymers, metals, polysaccharides, or emulsions based for pulmonary drug delivery that could provide an increased biological efficacy and better local and systemic action. © 2012 Informa Healthcare USA, Inc.

Cite

CITATION STYLE

APA

Kaur, G., Narang, R. K., Rath, G., & Goyal, A. K. (2012, February). Advances in pulmonary delivery of nanoparticles. Artificial Cells, Blood Substitutes, and Biotechnology. https://doi.org/10.3109/10731199.2011.592494

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free